Edition:
United Kingdom

Fennec Pharmaceuticals Inc (FENC.OQ)

FENC.OQ on NASDAQ Stock Exchange Capital Market

9.94USD
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
$9.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,390
52-wk High
$14.85
52-wk Low
$8.02

Chart for

About

Fennec Pharmaceuticals Inc., formerly Adherex Technologies Inc., is a biopharmaceutical company focused on cancer therapeutics. The Company's lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the... (more)
No analyst recommendations are available for .

Overall

Beta: -0.92
Market Cap(Mil.): $234.13
Shares Outstanding(Mil.): 15.86
Dividend: --
Yield (%): --

Financials

  FENC.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.37 -- --
ROI: -56.50 1.78 14.61
ROE: -56.50 3.28 16.33

BRIEF-Fennec Pharmaceuticals Receives Breakthrough Therapy Designation By FDA For Pedmark™

* FENNEC PHARMACEUTICALS RECEIVES BREAKTHROUGH THERAPY DESIGNATION BY FDA FOR PEDMARK™

27 Mar 2018

BRIEF-Fennec Says Phase 3 SIOPEL 6 Study Met Primary Endpoint

* FENNEC PROVIDES BUSINESS UPDATE AND ANNOUNCES FISCAL YEAR ENDED DECEMBER 31, 2017 FINANCIAL RESULTS

26 Mar 2018

BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark

* FENNEC PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION BY FDA FOR PEDMARK

21 Mar 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $134.47 +1.99
Roche Holding Ltd. (ROG.S) CHF239.95 +0.75
Roche Holding Ltd. (RO.S) CHF243.20 +0.20
Pfizer Inc. (PFE.N) $42.09 +0.67
Novartis AG (NOVN.S) CHF82.48 +0.76
Sanofi SA (SASY.PA) €73.30 +0.64
Abbott Laboratories (ABT.N) $64.72 +0.56
Merck & Co., Inc. (MRK.N) $69.06 +0.21
AstraZeneca plc (AZN.L) 5,930.00 -6.00
Amgen, Inc. (AMGN.OQ) $197.42 +0.98

Earnings vs. Estimates

No consensus analysis data available.